Skip to main navigation
Skip to search
Skip to main content
PolyU Scholars Hub Home
Help & FAQ
Link opens in a new tab
Search content at PolyU Scholars Hub
Home
Researchers
Units
Research output
Prizes
Activities
Press/Media
Student theses
Natural products targeting cancer stem cells: A revisit
Jiahua Cui
, Jiajun Qian
,
Larry Ming Cheung Chow
, Jinping Jia
Department of Applied Biology and Chemical Technology
The Hong Kong Polytechnic University
Research output
:
Journal article publication
›
Journal article
›
Academic research
›
peer-review
10
Link opens in a new tab
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Natural products targeting cancer stem cells: A revisit'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Natural Products
100%
Cancer Stem Cells
100%
Targeting Cancer Stem Cells
100%
Stilbenes
28%
Drug Resistance
28%
Therapeutic Potential
14%
In Cancer
14%
Chemotherapy
14%
Anticancer Drugs
14%
Multidrug Resistance
14%
Alkaloids
14%
Naphthoquinone
14%
Tumor Development
14%
Enhanced Expression
14%
Metastasis
14%
Self-renewal
14%
Shikonin
14%
Cancer Therapy
14%
Proliferation Resistance
14%
Anticancer
14%
Working Mechanism
14%
Tumor Recurrence
14%
Flavonoids
14%
ATP-binding Cassette Transporter A1 (ABCA1)
14%
Synthetic Analogues
14%
Stem Cell Population
14%
Structure-activity Relationship
14%
Quinones
14%
Cellular Targets
14%
Resveratrol
14%
Anti-apoptotic Factor
14%
New Drug Candidate
14%
Terpenoids
14%
Oncologic
14%
Invasive Cancer
14%
Polyketide Antibiotics
14%
G0 Phase
14%
Biologically Active Substances
14%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Natural Product
100%
Drug Resistance
25%
Chemotherapy
12%
ABC Transporter
12%
Structure Activity Relationship
12%
Antibiotics
12%
Antiapoptotic
12%
Lead Compound
12%
Flavonoid
12%
Tumor Recurrence
12%
Shikonin
12%
Tumor Invasion
12%
Stilbene
12%
Resveratrol
12%
Stilbene Derivative
12%
Terpenoid
12%
Naphthoquinone
12%
Polyketide
12%
Neoplasm
12%
Multidrug Resistance
12%
Anticancer Drug
12%